文献速递肝病

住院肝硬化患者血清氨水平与显性肝性脑病严重程度不相关

Serum Ammonia Levels Do Not Correlate With Overt Hepatic Encephalopathy Severity in Hospitalized Patients With Cirrhosis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2024-02-28

本文讨论氨在肝性脑病(HE)病理生理中的作用及临床检测氨水平的争议。引用一项551例接受乳果糖治疗的显性HE(OHE)患者研究,仅60%氨水平升高(>72 μmol/L),乳果糖剂量与是否检测氨无关,OHE缓解时间与氨水平无关;实验室间样本处理差异影响氨测定。

要点

  • 551例接受乳果糖治疗的OHE患者中仅60%氨水平升高(>72 μmol/L)。
  • 乳果糖剂量与是否检测氨水平无关,氨水平未指导治疗。
  • OHE缓解时间与氨水平无相关性。

核心结论

  • 血清氨水平与住院肝硬化患者OHE严重程度不相关,临床使用氨水平存在问题。

研究设计与样本

  • 本文为对现有文献的讨论,引用一项551例接受乳果糖治疗的OHE患者研究。

主要发现

  • 551例接受乳果糖治疗的OHE患者中仅60%氨水平升高(定义为>72 μmol/L)。
  • 乳果糖剂量与是否检测氨水平无相关性,氨水平升高与否未指导治疗。
  • OHE缓解时间与氨水平无相关性。
  • 样本处理与检测的实验室间差异可能影响氨测定。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although ammonia is involved in the pathophysiology of hepatic encephalopathy (HE), the use of ammonia levels in clinical practice is problematic.1-3 For example, in a study of 551 patients with overt HE (OHE) receiving lactulose who had ammonia levels tested, only 60% had an increased ammonia level (defined as >72 μmol/L).2 Overall, there was no correlation observed between lactulose dose and whether ammonia levels were obtained (ie, presence/absence of increased ammonia level did not guide therapy), or between time to OHE resolution and ammonia levels.2 Additionally, there is substantial interlaboratory variability in sample handling and processing, which may affect ammonia measurements.4.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Bajaj JS, Pyrsopoulos NT, Rahimi RS, et al. Serum Ammonia Levels Do Not Correlate With Overt Hepatic Encephalopathy Severity in Hospitalized Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2024. PMID: 38423347. doi:10.1016/j.cgh.2024.02.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。